NSE:KIMS's ROE % is ranked better than 66.08% of 625
companies
in the Healthcare Providers & Services industry
Industry Median: 5.84
vs NSE:KIMS: 10.88
Krishna Institute of Medical Sciences (NSE:KIMS) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Krishna Institute of Medical Sciences ROE % Related Terms
Krishna Institute of Medical Sciences ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's ROE % distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Krishna Institute of Medical Sciences (NSE:KIMS) has a ROE % of 7.56% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Krishna Institute of Medical Sciences and its competitors. This is 63% below median its historical median of 20.16. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #212 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 33.9%.
Is Krishna Institute of Medical Sciences' ROE % too high?
Krishna Institute of Medical Sciences' current ROE % of 7.56% is 63% below median its 10-year median of 20.16. The Healthcare Providers & Services industry median ROE % is 5.84. Krishna Institute of Medical Sciences' value of 7.56% is 29.5% above this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #212 out of 625 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #212 out of 625 companies for ROE %. This puts Krishna Institute of Medical Sciences in the upper half of its industry. The industry median ROE % is 5.84. Krishna Institute of Medical Sciences' value of 7.56% is 29.5% above this benchmark. While the company's 10-year median is 20.16 vs. the industry median of 5.84, Krishna Institute of Medical Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current ROE % of 7.56% is 29.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Krishna Institute of Medical Sciences and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current ROE % is 7.56%, which is 63% below median its own 10-year median of 20.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹776.44, compared to a current price of ₹805.45 — trading 3.7% above its estimated fair value. The current ROE % is 7.56%, which is 63% below median its 10-year median of 20.16 and 29.5% above the Healthcare Providers & Services industry median of 5.84. Krishna Institute of Medical Sciences' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current ROE % is 7.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be overvalued.
The current stock price of ₹805.45 is trading 3.7% above its estimated GF Value™ of ₹776.44.
GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.
Key valuation signals for NSE:KIMS:
ROE %: 7.56% (63% below median its 10-year median of 20.16)
GF Value™: ₹776.44 vs. price of ₹805.45 (3.7% above fair value)
Industry Position: 29.5% above the Healthcare Providers & Services median (#212 of 625)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Business Description
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
85GF Score
Get the complete analysis for NSE:KIMS
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
